La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Zimmer Biomet Holdings Crescita futura
Future criteri di controllo 1/6
Zimmer Biomet Holdings is forecast to grow earnings and revenue by 10% and 4.4% per annum respectively. EPS is expected to grow by 11.1% per annum. Return on equity is forecast to be 14.1% in 3 years.
Informazioni chiave
10.0%
Tasso di crescita degli utili
11.1%
Tasso di crescita dell'EPS
| Medical Equipment crescita degli utili | 17.4% |
| Tasso di crescita dei ricavi | 4.4% |
| Rendimento futuro del capitale proprio | 14.1% |
| Copertura analitica | Good |
| Ultimo aggiornamento | 12 Aug 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?
Jul 15
Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings
Jul 02Zimmer Biomet: Brighter Prospects In H2 2024
Jul 02Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24
Jun 19When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Jun 05Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24
May 21Zimmer Biomet Holdings: Moving Along
May 17The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising
May 02Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jan 29Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar
Jan 15The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Dec 31Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Dec 17Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Nov 06Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching
Oct 07Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes
Sep 21Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Sep 06Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Aug 08Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Jul 10We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease
Jun 27Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Jun 13A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 30Zimmer Biomet: Expect Growth Momentum To Continue
May 26Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
May 04At US$129, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?
Apr 02Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Appealing
Mar 13A Look At The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Feb 21Improving Ortho Performance At Zimmer Biomet Is Encouraging
Feb 09Zimmer Biomet Q4 2022 Earnings Preview
Feb 02We Think Zimmer Biomet Holdings (NYSE:ZBH) Can Stay On Top Of Its Debt
Jan 19Zimmer Biomet to acquire soft tissue healing company Embody
Jan 05Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2026 | 8,456 | 1,342 | 1,719 | 2,198 | 20 |
| 12/31/2025 | 8,090 | 1,200 | 1,500 | 2,080 | 26 |
| 12/31/2024 | 7,728 | 1,013 | 1,056 | 1,629 | 27 |
| 6/30/2024 | 7,525 | 997 | 821 | 1,523 | N/A |
| 3/31/2024 | 7,452 | 964 | 807 | 1,502 | N/A |
| 12/31/2023 | 7,394 | 1,024 | 892 | 1,582 | N/A |
| 9/30/2023 | 7,279 | 474 | 560 | 1,237 | N/A |
| 6/30/2023 | 7,196 | 506 | 724 | 1,351 | N/A |
| 3/31/2023 | 7,108 | 450 | 858 | 1,355 | N/A |
| 12/31/2022 | 6,940 | 290 | 839 | 1,285 | N/A |
| 9/30/2022 | 6,892 | 366 | 970 | 1,406 | N/A |
| 6/30/2022 | 6,908 | 334 | 957 | 1,389 | N/A |
| 3/31/2022 | 6,889 | 325 | 1,078 | 1,490 | N/A |
| 12/31/2021 | 6,827 | 445 | 1,074 | 1,499 | N/A |
| 9/30/2021 | 7,135 | 834 | 1,164 | 1,559 | N/A |
| 6/30/2021 | 7,379 | 914 | 1,132 | 1,507 | N/A |
| 3/31/2021 | 6,842 | 563 | 618 | 1,000 | N/A |
| 12/31/2020 | 6,128 | -11 | 834 | 1,205 | N/A |
| 9/30/2020 | 7,065 | -152 | 762 | 1,203 | N/A |
| 6/30/2020 | 7,028 | 37 | 899 | 1,399 | N/A |
| 3/31/2020 | 7,791 | 377 | 1,008 | 1,753 | N/A |
| 12/31/2019 | 7,982 | 1,132 | 865 | 1,586 | N/A |
| 9/30/2019 | 7,928 | -90 | 830 | 1,542 | N/A |
| 6/30/2019 | 7,872 | -359 | 750 | 1,448 | N/A |
| 3/31/2019 | 7,891 | -308 | 1,087 | 1,541 | N/A |
| 12/31/2018 | 7,933 | -379 | 1,308 | 1,747 | N/A |
| 9/30/2018 | 7,930 | 1,753 | 1,324 | 1,771 | N/A |
| 6/30/2018 | 7,907 | 1,690 | 1,324 | 1,750 | N/A |
| 3/31/2018 | 7,849 | 1,689 | N/A | 1,797 | N/A |
| 12/31/2017 | 7,803 | 1,814 | N/A | 1,582 | N/A |
| 9/30/2017 | 7,748 | 652 | N/A | 1,807 | N/A |
| 6/30/2017 | 7,768 | 712 | N/A | 1,696 | N/A |
| 3/31/2017 | 7,752 | 497 | N/A | 1,635 | N/A |
| 12/31/2016 | 7,668 | 306 | N/A | 1,632 | N/A |
| 9/30/2016 | 7,604 | 363 | N/A | 1,468 | N/A |
| 6/30/2016 | 7,534 | 227 | N/A | 1,214 | N/A |
| 3/31/2016 | 6,767 | 84 | N/A | 1,031 | N/A |
| 12/31/2015 | 5,998 | 147 | N/A | 850 | N/A |
| 9/30/2015 | 5,287 | 174 | N/A | 742 | N/A |
| 6/30/2015 | 4,631 | 325 | N/A | 899 | N/A |
| 3/31/2015 | 4,646 | 670 | N/A | 956 | N/A |
| 12/31/2014 | 4,673 | 720 | N/A | 1,061 | N/A |
| 9/30/2014 | 4,691 | 802 | N/A | 999 | N/A |
| 6/30/2014 | 4,659 | 784 | N/A | 1,036 | N/A |
| 3/31/2014 | 4,646 | 764 | N/A | 971 | N/A |
| 12/31/2013 | 4,623 | 780 | N/A | 963 | N/A |
| 9/30/2013 | 4,563 | 678 | N/A | 1,031 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: ZBH's forecast earnings growth (10% per year) is above the savings rate (2.5%).
Guadagni vs Mercato: ZBH's earnings (10% per year) are forecast to grow slower than the US market (15.1% per year).
Guadagni ad alta crescita: ZBH's earnings are forecast to grow, but not significantly.
Ricavi vs Mercato: ZBH's revenue (4.4% per year) is forecast to grow slower than the US market (8.8% per year).
Ricavi ad alta crescita: ZBH's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: ZBH's Return on Equity is forecast to be low in 3 years time (14.1%).